RecruitingPhase 3NCT04727424

Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Cardresearch
Principal Investigator: Gilmar Reis, MD,PhD.
Cardresearch - Cardiologia Assistencial e de Pesquisa
Intervention: Spirulin Platensis(dietary_supplement)
Enrollment: 7819 enrolled
Eligibility: 18 years · All sexes
Timeline: 2021 – 2024

Study locations (12)

CARDRESEARCH - Cardiologia Assistencial e de Pesquisa, Belo Horizonte, Minas Gerais, Brazil
City of Betim, Betim, Minas Gerais, Brazil
City of Brumadinho, Brumadinho, Minas Gerais, Brazil
Hospital e Maternidade Santa Rita, Contagem, Minas Gerais, Brazil
City of Governador Valadares, Governador Valadares, Minas Gerais, Brazil
City of Ibirité, Ibirité, Minas Gerais, Brazil
City of Igarapé, Igarapé, Minas Gerais, Brazil
Centro Universitário FIPMOC, Montes Claros, Minas Gerais, Brazil
City of Nova Lima, Nova Lima, Minas Gerais, Brazil
Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais, Brazil
City of Santa Luzia, Santa Luzia, Minas Gerais, Brazil
City of Sete Lagoas, Sete Lagoas, Minas Gerais, Brazil

Collaborators

Cytel Inc. · McMaster University · Fastgrants · Eiger BioPharmaceuticals · RainWater Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04727424 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome →

← Back to all trials